MML Investors Services
PFE icon

MML Investors Services’s Pfizer PFE Stock Holding History

MML Investors Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6M Buy
1,393,942
+291,529
+26% +$7.63M 0.07% 292
2026
Q1 		$31M Sell
1,102,413
-278,633
-20% -$7.42M 0.09% 234
2025
Q4 		$34.4M Sell
1,381,046
-257,817
-16% -$6.5M 0.08% 235
2025
Q3 		$41.8M Buy
1,638,863
+176,206
+12% +$4.35M 0.11% 189
2025
Q2 		$35.5M Buy
1,462,657
+133,399
+10% +$3.11M 0.1% 202
2025
Q1 		$33.7M Buy
1,329,258
+238,958
+22% +$6.25M 0.11% 194
2024
Q4 		$28.9M Sell
1,090,300
-296,838
-21% -$8.05M 0.1% 207
2024
Q3 		$40.1M Buy
1,387,138
+53,486
+4% +$1.56M 0.15% 155
2024
Q2 		$37.3M Buy
1,333,652
+86,684
+7% +$2.39M 0.15% 147
2024
Q1 		$34.6M Buy
1,246,968
+80,619
+7% +$2.24M 0.14% 162
2023
Q4 		$33.6M Buy
1,166,349
+166,587
+17% +$5.04M 0.15% 149
2023
Q3 		$33.2M Buy
999,762
+68,579
+7% +$2.43M 0.18% 116
2023
Q2 		$34.2M Buy
931,183
+137,616
+17% +$5.36M 0.19% 111
2023
Q1 		$32.4M Sell
793,567
-26,827
-3% -$1.16M 0.23% 92
2022
Q4 		$42M Buy
820,394
+68,591
+9% +$3.29M 0.28% 76
2022
Q3 		$32.9M Buy
751,803
+40,020
+6% +$1.94M 0.25% 84
2022
Q2 		$37.3M Buy
711,783
+3,014
+0.4% +$154K 0.28% 71
2022
Q1 		$36.7M Buy
708,769
+25,019
+4% +$1.3M 0.26% 77
2021
Q4 		$40.4M Sell
683,750
-5,146
-0.7% -$255K 0.29% 66
2021
Q3 		$29.6M Sell
688,896
-6,317
-0.9% -$280K 0.24% 88
2021
Q2 		$27.2M Buy
695,213
+28,301
+4% +$1.1M 0.23% 92
2021
Q1 		$24.2M Buy
666,912
+39,806
+6% +$1.41M 0.23% 97
2020
Q4 		$23.1M Buy
627,106
+105,162
+20% +$3.86M 0.25% 91
2020
Q3 		$18.2M Buy
521,944
+46,882
+10% +$1.64M 0.23% 101
2020
Q2 		$14.7M Buy
475,062
+33,112
+7% +$1.12M 0.2% 120
2020
Q1 		$13.7M Sell
441,950
-101,602
-19% -$3.46M 0.24% 106
2019
Q4 		$20.2M Buy
543,552
+70,569
+15% +$2.51M 0.29% 83
2019
Q3 		$16.1M Sell
472,983
-10,106
-2% -$367K 0.26% 87
2019
Q2 		$19.9M Buy
483,089
+28,737
+6% +$1.14M 0.28% 86
2019
Q1 		$18.3M Buy
454,352
+62,131
+16% +$2.49M 0.28% 91
2018
Q4 		$16.2M Sell
392,221
-56,223
-13% -$2.33M 0.29% 92
2018
Q3 		$18.8M Buy
448,444
+110,839
+33% +$4.27M 0.32% 78
2018
Q2 		$11.6M Buy
337,605
+16,055
+5% +$549K 0.25% 99
2018
Q1 		$10.8M Sell
321,550
-33,001
-9% -$1.13M 0.23% 107
2017
Q4 		$12.2M Sell
354,551
-47,156
-12% -$1.61M 0.23% 99
2017
Q3 		$13.6M Sell
401,707
-62,493
-13% -$2.01M 0.28% 87
2017
Q2 		$14.8M Buy
464,200
+22,140
+5% +$698K 0.28% 85
2017
Q1 		$14.3M Buy
+442,060
New +$13.9M 0.29% 41

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services's PFE Position: Q2 2026 in Review

MML Investors Services increased its Pfizer (PFE) stake by 26% in Q2 2026, buying an estimated $7.63M and bringing the position to 1,393,942 shares worth $33.6M. The position accounts for 0.07% of the portfolio, ranked #292.

MML Investors Services first reported a position in PFE in Q1 2017 and has held it in 38 quarters since. The position peaked at $42M in Q4 2022. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MML Investors Services held 1,393,942 shares of Pfizer worth $33.6M as of Q2 2026.
  • MML Investors Services bought 291,529 Pfizer shares in Q2 2026, an estimated $7.63M.
  • Pfizer made up 0.07% of MML Investors Services's portfolio in Q2 2026, its #292 holding.
  • MML Investors Services first reported a position in Pfizer in Q1 2017 and has held it in 38 quarters since.
  • MML Investors Services's Pfizer position peaked at $42M in Q4 2022.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.